MBHB Partner Kevin E. Noonan sits down with the AUTM on the Air podcast to discuss the latest legal developments in the CRISPR patent disputes and potential implications for the future of biotechnology.
Dive into the high-stakes world of gene editing in the newest episode of AUTM on the Air, featuring Dr. Kevin Noonan, a seasoned patent lawyer and molecular biologist. In this episode, Dr. Noonan breaks down the CRISPR patent disputes between the Broad Institute and CVC, discussing why it matters for tech transfer, the latest legal rulings and what it all means for the future of biotechnology. From U.S. and European patent offices to the impact on CRISPR research, this is a must-listen for anyone following groundbreaking advancements in gene editing! 🌍🧬 Listen now: Apple: https://apple.co/3ebWO4n Spotify: https://spoti.fi/3C2dVO8 If you are interested in listening to the episode with captioning, please consider using Live Caption from Google: https://bit.ly/3C9s4cu